2019年全球蛆剧集市场的价值高达950万美元,预计将在预测期内以9.7%的CAGR增长。增加慢性病,即糖尿病,癌症,是负责市场增长的关键因素。虽然长期糖尿病是糖尿病足溃疡的原因,但预计糖尿病的增加案例会积极影响蛆清卓人市场的扩张。
Biobags&Pocket Larva是用于治疗静脉溃疡,糖尿病足溃疡和压力溃疡的最新技术。此外,销售报酬的燃烧和可用性的增加还进一步推动了蛆清卓人市场的增长。
Know more about this report:请求样本页面
增长司机
Cancer is a global concern as it is the leading cause of death. According to the World Health Organization (WHO), cancer is the major reason for death worldwide and approximately one in every six deaths happens because of cancer. In addition, over 70.0% of cancer-related deaths prevail in middle and lower-income level countries due to the increasing cases of chronic conditions.
Increasing cases of trauma, burns, and street accidents globally are expected to fuel the maggot debridement market growth. As per the World Health Organization (WHO) in 2018 around 1,000,000 people in India have gone through severe or moderate burns. Besides this, according to the NCBI, in 2017, countries including Finland, Bulgaria, South Korea, the Netherlands, China, and the U.K. has registered a rise in the cases of burn wounds.
据美国人手术协会的说法,2017年,近120万人在全球上死亡,道路事故每天都在约3,242人死亡。生物材料和皮肤替代品被广泛用于愈合所有类型的烧伤伤口。因此,事故数量的上涨导致对产品的需求,预计将在预测期间推动蛆杂志市场增长。
The maggot debridement market is primarily segmented based on administration type, application, end-use, and geographic region.
通过管理类型 |
By Application |
By End-Use |
By Region |
|
|
|
|
Know more about this report:请求样本页面
Based on product type, the global maggot debridement market is categorized into Biobags, and Loose Larva. Comparatively, biobags segment held the major market share, in 2019, due to the increasing occurrence of chronic wounds & rising surgeries globally. While the Biobags are safe & reliable for usage and delivers outcomes in just 28 days. Furthermore, the segment is expected to witness significant growth over the projected period.
松散的幼虫伤口清创治疗是一种古老而保守的过程。每次/平方米5-8幼虫剂量。CM直接在伤口内施用,开发外敷料以含有幼虫到治疗区域。整个治疗方法需要左右14天的伤口清创。然而,与Biobags相比,松散的幼虫不如使用,这可能会妨碍全球蛆杂交市场的节段增长在预测期间。
Based on application, the global maggot debridement market is categorized into acute and chronic wounds. The chronic wound segment held a significant share in 2019. The segment is expected to witness significant growth over the projected period as maggot debridement is widely used in chronic wounds. Meanwhile, chronic wounds include venous leg ulcers, diabetic foot ulcers, and pressure ulcers.
Additionally, the pressure ulcer segment is expected to achieve the fastest growth rate during the forecast period. Pressure ulcers or bedsores usually occur owing to the intense pressure on the skin for a larger time. It is widely caused by hospital stays & is commonly seen in the geriatric population. In addition to this, pressure ulcers prevail mostly at the bony areas of the human body including hips, ankles, and tailbone. However, increasing the geriatric populace globally is a key factor fueling the maggot debridement market segment.
基于最终用途,全球蛆清卓人市场分为医院,伤口护理中心,诊所等。由于慢性伤口案件上升,医院在2019年举行了重大市场份额。此外,糖尿病脚和静脉腿部溃疡的上升案例是推动细分增长的关键因素。然而,手术伤口事件正在上升,导致手术的增加进一步推动细分的生长。
基于该地区,全球蛆清卓人市场已分为北美,欧洲,拉丁美洲,亚太和中东和非洲。其中,北美有主要的市场份额。体育伤害案件上升,越来越多的道路事故和该地区各种关键球员的存在是推动市场增长的主要因素。此外,预计发达的医疗保健基础设施和充足的报销政策的存在旨在为区域蛆清卓人市场的增betway体育亚洲版入口长提供燃料。
由于新兴经济体在内的新兴经济体,亚太地区目睹了亚太地区以实现预测期限的重大增长。此外,该地区的扩大医疗旅游业进一步负责该地区对这些产品的需求上升。例如,根据印度商业智能和统计局的出口卫生服务的报告,2016年,印度有大约58,300名医疗游客必威开户注册。
在全球蛆清卓人市场中运营的主要球员专注于合资企业,合作,区域扩张,并通过进入未被发现的市场来强化其全球印象的投资。此外,该公司还专注于开发技术先进的产品,以维持竞争。
Smith & Nephew has a wide product portfolio in the global market including surgical gels, devices, and ointments. Owing to its wide product portfolio & good brand image, the company can secure its dominating position in the global maggot debridement market. Additionally, the company has a wide distribution channel in 100 countries globally. Moreover, the company has well-established marketing channels in developed markets including the US, which had generated 50% of its revenue from the US alone in 2019.
Some of the major players operating the global maggot debridement market include Smith & Nephew, Monarch Labs, Coloplast, Mega Pharma (Pvt) Ltd., BioMonde, B. Braun Melsungen AG, Mölnlycke Healthcare, ConvaTec, Lohmann & Rauscher, Arobella Medical, LLC Integra Lifesciences, Advancis Medical, DeRoyal Industries, RLS Global, EZ Debride & Sanara MedTech Inc.